We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The president and chief operating officer (COO) of Barr Pharmaceuticals, Paul Bisaro, will be leaving the company to become president and CEO of Watson Pharmaceuticals effective Sept. 4, according to the companies’ Aug. 2 announcements.